CMS has advised Asga Pensionskassen Genossenschaft and Swiss Prime Anlagestiftung on the acquisition of a notable commercial and residential property in Florissant, Geneva, for a consideration of CHF 197 million. Swiss Prime Investment Foundation was founded
Tags :Slider
Global growth equity investor Verlinvest has partnered with Sinomedica, a Swiss group of acupuncture centres. Verlinvest is a global growth equity investor that backs category-defining consumer brands. From the other side, Sinomedica is pioneering a
Dätwyler Holding has placed a CHF 240 million fixed rate bond on 15 June 2022. The bond bears interest of 2.1% and has a term of five years. Zürcher Kantonalbank managed the placement of the bond based
Schellenberg Wittmer has advised Julius Baer Group on its sale of Fransad Gestion, a major Swiss independent wealth manager, to the management team of the independent wealth manager and an industrial partner. The management team
Radicant, the BLKB subsidiary new firm, has received a FINMA banking licence. Radicant is the first sustainable, collaborative and fully digital bank in Switzerland with a strong focus on personalized and sustainable financial solutions. Founded
Solstis has joined the BKW Group following its acquisition by BKW Building Solutions, a BKW Group company. This acquisition is part of the Group’s growth strategy. BKW Building Solutions is a regionally based network
Credit Suisse Group has priced the issuance of USD 1.65 bn 9.750 per cent. Perpetual Tier 1 Contingent Write-down Capital Notes. The Notes are «high trigger» regulatory capital instruments that are eligible to fulfill
Niederer Kraft Frey has advised Kernkraftwerk Leibstadt on the placement of a CHF 200 million bond (CHF 175 million plus CHF 25 million top up) with a term to maturity of 5 years. The net proceeds will be used
Riverside Company, a global private equity investor focused on the smaller end of the middle market, has announced the acquisition of Geneva-based Actando. The software and services company Actando is a global learning organization that
VectivBio Holding a clinical-stage biopharmaceutical company, has announced a combined gross proceeds from public offering and private sale of USD 50 million. On one side, the company has announced the pricing of a follow-on public offering
